NTLA

Intellia Therapeutics Inc

Jun 23 • 04:00PM ET

15.25

-0.50 -3.17 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BEAM CRSP EDIT VIR BMRN IONS ALNY INCY VRTX SNDX

| Held by: ARKK XBI VTI ARKG VB IWM VBK VXF IWN IBB

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.53	Insider Own	4.46%	Shs Outstand	139.72M	Perf Week	2.21%
Market Cap	2.13B	Forward P/E	-	EPS next Y	-1.85	Insider Trans	1.04%	Shs Float	133.49M	Perf Month	23.28%
Enterprise Value	1.84B	PEG	-	EPS next Q	-0.81	Inst Own	76.24%	Short Float	36.34%	Perf Quarter	16.32%
Income	-394.60M	P/S	32.24	EPS this Y	15.48%	Inst Trans	4.79%	Short Ratio	7.60	Perf Half Y	71.73%
Sales	66.09M	P/B	2.96	EPS next Y	42.56%	ROA	-45.23%	Short Interest	48.52M	Perf YTD	69.63%
Book/sh	5.16	P/C	5.67	EPS next 5Y	43.90%	ROE	-56.34%	52W High	28.25 -46.02%	Perf Year	65.22%
Cash/sh	2.69	P/FCF	-	EPS past 3/5Y	14.82% -9.70%	ROIC	-57.83%	52W Low	7.95 91.82%	Perf 3Y	-62.79%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	9.09% 3.13%	Gross Margin	76.32%	Volatility	8.90% 8.85%	Perf 5Y	-81.76%
Dividend TTM	-	EV/Sales	27.77	EPS Y/Y TTM	32.42%	Oper. Margin	-636.56%	ATR (14)	1.23	Perf 10Y	-42.37%
Dividend Ex-Date	-	Quick Ratio	6.10	Sales Y/Y TTM	45.04%	Profit Margin	-597.04%	RSI (14)	58.47	Recom	2.23
Dividend Gr. 3/5Y	- -	Current Ratio	6.10	EPS Q/Q	26.48%	SMA20	10.37%	Beta	1.76	Target Price	26.61
Payout	-	Debt/Eq	0.13	Sales Q/Q	-9.50%	SMA50	10.25%	Rel Volume	0.77	Prev Close	15.75
Employees	377	LT Debt/Eq	0.10	Earnings	May 11 BMO	SMA200	12.91%	Avg Volume	6.38M	Price	15.25
IPO	May 06, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	11.06% 8.99%	Trades		Volume	4,882,288	Change	-3.17%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)